- Home
- VWAV vs NKTR Comparison
VWAV vs NKTR Comparison
Compare VWAV & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VWAV
- NKTR
- Stock Information
- Founded
- VWAV 2024
- NKTR 1990
- Country
- VWAV United States
- NKTR United States
- Employees
- VWAV N/A
- NKTR N/A
- Industry
- VWAV Computer Software: Prepackaged Software
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- VWAV Technology
- NKTR Health Care
- Exchange
- VWAV Nasdaq
- NKTR Nasdaq
- Market Cap
- VWAV 115.5M
- NKTR 108.3M
- IPO Year
- VWAV N/A
- NKTR 1994
- Fundamental
- Price
- VWAV $7.32
- NKTR $27.26
- Analyst Decision
- VWAV
- NKTR Strong Buy
- Analyst Count
- VWAV 0
- NKTR 6
- Target Price
- VWAV N/A
- NKTR $81.67
- AVG Volume (30 Days)
- VWAV 15.1M
- NKTR 673.7K
- Earning Date
- VWAV 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- VWAV N/A
- NKTR N/A
- EPS Growth
- VWAV N/A
- NKTR N/A
- EPS
- VWAV N/A
- NKTR N/A
- Revenue
- VWAV N/A
- NKTR $74,934,000.00
- Revenue This Year
- VWAV N/A
- NKTR N/A
- Revenue Next Year
- VWAV N/A
- NKTR N/A
- P/E Ratio
- VWAV N/A
- NKTR N/A
- Revenue Growth
- VWAV N/A
- NKTR N/A
- 52 Week Low
- VWAV $2.06
- NKTR $6.48
- 52 Week High
- VWAV $12.59
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- VWAV N/A
- NKTR 66.00
- Support Level
- VWAV N/A
- NKTR $21.60
- Resistance Level
- VWAV N/A
- NKTR $23.98
- Average True Range (ATR)
- VWAV 0.00
- NKTR 1.48
- MACD
- VWAV 0.00
- NKTR 0.22
- Stochastic Oscillator
- VWAV 0.00
- NKTR 86.67
About VWAV VisionWave Holdings Inc. Common Stock
VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.